Literature DB >> 6339548

Rapid diagnosis of varicella-zoster virus infection by detection of viral deoxythymidine kinase in serum and vesicle fluid.

C F Källander, J S Gronowitz, E Olding-Stenkvist.   

Abstract

A sensitive enzyme assay utilizing [125I]iododeoxyuridine as the substrate and CTP as the phosphate donor in combination with isozyme-specific antisera was used for direct detection and typing of herpesvirus deoxythymidine kinase (dTk) in clinical specimens. An investigation of 16 coded vesicle fluid specimens, taken in connection with varicella-zoster virus (VZV) and herpes simplex virus infections, revealed viral dTk activity in 14 samples. All positive samples except one were taken within 5 days after the onset of illness. Serological typing of the dTk activities easily established whether the vesicles were caused by VZV, herpes simplex virus type 1, or herpes simplex virus type 2. The results were obtainable within 5 h and were in agreement with the results achieved by immunofluorescence tests or by virus isolation when positive. Acute- and convalescent-phase sera from patients with VZV infections were analyzed with regard to dTk isozyme composition. All sera collected within 5 days after the onset of varicella were found to contain elevated levels of dTk activity. By the use of isozyme-specific antisera and gel electrophoresis, it was possible to show the presence of both cellular and VZV dTk's. Among the 13 acute-phase sera from zoster patients, only 2 were found to be VZV dTk positive. Convalescent sera, in most cases collected 15 days or more after the onset of illness, were also found to be devoid of VZV dTk. The relevance of the results and the possible use of these methods for viral diagnostics are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339548      PMCID: PMC272623          DOI: 10.1128/jcm.17.2.280-287.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Presence of antibody against herpes simplex virus-specified thymidine kinase and deoxyribonuclease in human sera.

Authors:  Y C Cheng; P J Hoffmann; M P Kung
Journal:  IARC Sci Publ       Date:  1978

2.  Properties of mitochondrial thymidine kinases of parental and enzyme-deficient HeLa cells.

Authors:  S Kit; W C Leung; D Trkula
Journal:  Arch Biochem Biophys       Date:  1973-10       Impact factor: 4.013

3.  Rapid diagnosis of varicella-zoster infections by agar-gel diffusion.

Authors:  S A Uduman; A A Gershon; P A Brunell
Journal:  J Infect Dis       Date:  1972-08       Impact factor: 5.226

4.  Expression of thymidine kinase variants is a function of the replicative state of cells.

Authors:  R Adler; B R McAuslan
Journal:  Cell       Date:  1974-06       Impact factor: 41.582

5.  Serological properties of thymidine kinase produced in cells infected with type 1 or type 2 herpes virus.

Authors:  M E Thouless
Journal:  J Gen Virol       Date:  1972-12       Impact factor: 3.891

6.  Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.

Authors:  N J Schmidt; E H Lennette; R L Magoffin
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

Review 7.  Viral-associated and induced enzymes.

Authors:  S Kit
Journal:  Pharmacol Ther B       Date:  1979

8.  Early diagnosis of virus-caused vesicular rashes by immunofluorescence on skin biopsies. I. Varicella, zoster and herpes simplex.

Authors:  E Olding-Stenkvist; M Grandien
Journal:  Scand J Infect Dis       Date:  1976

9.  Complement-fixing reactivity of Varicella-Zoster virus subunit antigens with sera from homotypic infections and heterotypic Herpes simplex virus infections.

Authors:  N J Schmidt; J Dennis; E H Lennette
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

10.  Biochemical and immunological characterization of deoxythymidine kinase of thymidine kinaseless HeLa cells biochemically transformed by herpes simplex virus type.

Authors:  Y C Cheng; K C Chadha; R G Hughes
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

View more
  6 in total

Review 1.  Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications.

Authors:  M Hallek; L Wanders; S Strohmeyer; B Emmerich
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

2.  Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase.

Authors:  A R Karlström; C F Källander; G Abele; A Larsson
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

3.  Neuron specific enolase (NSE) and thymidine kinase (TK) as markers in biological fluids of brain tumor patients.

Authors:  A Boiardi; L Munari; A Silvani; C L Solero; E Bombardieri
Journal:  Ital J Neurol Sci       Date:  1990-08

4.  Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture.

Authors:  G Abele; A Karlström; J Harmenberg; S Shigeta; A Larsson; B Lindborg; B Wahren
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

5.  Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA.

Authors:  A R Karlström; M Neumüller; J S Gronowitz; C F Källander
Journal:  Mol Cell Biochem       Date:  1990-01-18       Impact factor: 3.396

Review 6.  Recognition and treatment of shingles.

Authors:  A F Nikkels; G E Piérard
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.